Route | Form | Dose |
Cmax (ng/mL) |
Tmax (hours) |
t1/2 (hours) | ||
---|---|---|---|---|---|---|---|
Oral | Capsule | 200 mg | 4.3–11.7 | 2–2.5 | ? | ||
Sublingual | Tablet [a] | 100 mg | 13.5 | 1–4 | ~6–7 | ||
Suspension | 100 mg | 17.6 | 0.5–1 | ? | |||
Vaginal | Tablet [a] | 100 mg | 10.9 | 6–7 | 13.7 | ||
Capsule | 100 mg | 9.7 | 1–3 | ? | |||
Intramuscular injection |
Oil solution | 50 mg | 14.3 | 8.7 | ? | ||
100 mg | 113 | 6.7 | 22.3 | ||||
Aq. solution [b] | 100 mg | 440 | 0.88 | 14.3 | |||
Subcutaneous injection |
Aq. solution [b] | 25 mg | 57.8 | 0.92 | 13.1 | ||
50 mg | 103 | 0.92 | 17.2 | ||||
100 mg | 235–300 | 0.92 | 17.2–17.6 | ||||
|